These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 10338002)
1. Mutations of the WT1 gene in childhood nonlymphoid hematological malignancies. Miyagawa K; Hayashi Y; Fukuda T; Mitani K; Hirai H; Kamiya K Genes Chromosomes Cancer; 1999 Jun; 25(2):176-83. PubMed ID: 10338002 [TBL] [Abstract][Full Text] [Related]
2. The role of Wilms' tumor genes. Hirose M J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307 [TBL] [Abstract][Full Text] [Related]
3. Fusion of the EWS1 and WT1 genes as a result of the t(11;22)(p13;q12) translocation in desmoplastic small round cell tumors. Benjamin LE; Fredericks WJ; Barr FG; Rauscher FJ Med Pediatr Oncol; 1996 Nov; 27(5):434-9. PubMed ID: 8827070 [TBL] [Abstract][Full Text] [Related]
4. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170 [TBL] [Abstract][Full Text] [Related]
5. Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association. Renneville A; Boissel N; Zurawski V; Llopis L; Biggio V; Nibourel O; Philippe N; Thomas X; Dombret H; Preudhomme C Cancer; 2009 Aug; 115(16):3719-27. PubMed ID: 19536888 [TBL] [Abstract][Full Text] [Related]
6. [Expression of Wilms' tumor gene (WT1) in leukemias and its clinical implication]. Wu X; Wang Y; Pei X Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):16-9. PubMed ID: 10921096 [TBL] [Abstract][Full Text] [Related]
7. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies. Taketani T; Taki T; Takita J; Tsuchida M; Hanada R; Hongo T; Kaneko T; Manabe A; Ida K; Hayashi Y Genes Chromosomes Cancer; 2003 Sep; 38(1):1-7. PubMed ID: 12874780 [TBL] [Abstract][Full Text] [Related]
8. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker. Roberts DJ; Haber D; Sklar J; Crum CP Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523 [TBL] [Abstract][Full Text] [Related]
9. Genotype/phenotype correlations in Wilms' tumor. Huff V Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067 [TBL] [Abstract][Full Text] [Related]
10. [Genetic diagnosis of leukemia: diagnosis of relapse and complete remission, and prediction of leukemia onset]. Sugiyama H Rinsho Byori; 2000 Feb; 48(2):155-61. PubMed ID: 10804819 [TBL] [Abstract][Full Text] [Related]
11. The significance of detecting WT1 expression in childhood acute leukemias. Hu SY; Gu WY; Chen ZX; Wang XL; Cen JN; He HL; Chai YH; Chen CS Pediatr Hematol Oncol; 2010 Nov; 27(8):581-91. PubMed ID: 20863155 [TBL] [Abstract][Full Text] [Related]
12. [The minimal residual disease (MRD) in hematological malignancies]. Yokota S; Okamoto T Gan To Kagaku Ryoho; 2001 Jun; 28(6):762-8. PubMed ID: 11432342 [TBL] [Abstract][Full Text] [Related]
13. Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies. Minelli A; Maserati E; Rossi G; Bernardo ME; De Stefano P; Cecchini MP; Valli R; Albano V; Pierani P; Leszl A; Sainati L; Lo Curto F; Danesino C; Locatelli F; Pasquali F Genes Chromosomes Cancer; 2004 Jul; 40(3):165-71. PubMed ID: 15138996 [TBL] [Abstract][Full Text] [Related]
14. WT1-specific serum antibodies in patients with leukemia. Gaiger A; Carter L; Greinix H; Carter D; McNeill PD; Houghton RL; Cornellison CD; Vedvick TS; Skeiky YA; Cheever MA Clin Cancer Res; 2001 Mar; 7(3 Suppl):761s-765s. PubMed ID: 11300470 [TBL] [Abstract][Full Text] [Related]
15. Wilms tumor and the WT1 gene. Lee SB; Haber DA Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525 [TBL] [Abstract][Full Text] [Related]
17. WT1 protein expression in childhood acute leukemia. Kerst G; Bergold N; Gieseke F; Coustan-Smith E; Lang P; Kalinova M; Handgretinger R; Trka J; Müller I Am J Hematol; 2008 May; 83(5):382-6. PubMed ID: 18161786 [TBL] [Abstract][Full Text] [Related]
18. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression. Doubek M; Palasek I; Pospisil Z; Borsky M; Klabusay M; Brychtova Y; Jurcek T; Jeziskova I; Krejci M; Dvorakova D; Mayer J Exp Hematol; 2009 Jun; 37(6):659-72. PubMed ID: 19463768 [TBL] [Abstract][Full Text] [Related]
19. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Algar EM; Khromykh T; Smith SI; Blackburn DM; Bryson GJ; Smith PJ Oncogene; 1996 Mar; 12(5):1005-14. PubMed ID: 8649791 [TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. Barragán E; Cervera J; Bolufer P; Ballester S; Martín G; Fernández P; Collado R; Sayas MJ; Sanz MA Haematologica; 2004 Aug; 89(8):926-33. PubMed ID: 15339675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]